SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-208741
Filing Date
2012-05-03
Accepted
2012-05-03 16:53:03
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d340942d10q.htm 10-Q 502802
2 LICENSE AND CO-DEVELOPMENT AGREEMENT d340942dex101.htm EX-10.1 344904
3 SECTION 302 CEO CERTIFICATION d340942dex311.htm EX-31.1 9252
4 SECTION 302 CFO CERTIFICATION d340942dex312.htm EX-31.2 9509
5 SECTION 906 CEO CERTIFICATION d340942dex321.htm EX-32.1 3665
6 SECTION 906 CFO CERTIFICATION d340942dex322.htm EX-32.2 3753
  Complete submission text file 0001193125-12-208741.txt   2280816

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thld-20120331.xml EX-101.INS 264076
8 XBRL TAXONOMY EXTENSION SCHEMA thld-20120331.xsd EX-101.SCH 9198
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20120331_cal.xml EX-101.CAL 27478
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20120331_lab.xml EX-101.LAB 93665
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20120331_pre.xml EX-101.PRE 58873
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 12810480
SIC: 2834 Pharmaceutical Preparations